Experience in 102 Non-melanoma Skin Cancer with Mohs Micrographic Surgery.
- Author:
Bo Hee YANG
1
;
Ji Won BYUN
;
Seung Gyu LEE
;
Seung Gyun IN
;
Hyeon Sook LEE
;
Kee Yang CHUNG
;
Jeong Hyun SHIN
;
Gwang Seong CHOI
;
Hee Jin SONG
Author Information
1. Department of Dermatology, Inha University School of Medicine, Incheon, Korea. dmhjsong@naver.com
- Publication Type:Original Article
- Keywords:
Mohs micrographic surgery;
Skin cancer
- MeSH:
Carcinoma, Basal Cell;
Carcinoma, Squamous Cell;
Humans;
Lymph Nodes;
Mohs Surgery;
Neoplasm Metastasis;
Recurrence;
Retrospective Studies;
Safety;
Skin;
Skin Neoplasms;
Surveys and Questionnaires
- From:Korean Journal of Dermatology
2012;50(11):931-936
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Mohs micrographic surgery (MMS) is a specialized type of minimal marginal surgery, which offers superior cure rates to other options in the treatment of non-melanoma skin cancers. OBJECTIVE: The aim of this study is to investigate the clinical characteristics and recurrence rate of the non-melanoma skin cancer and to estimate the safeties of MMS. METHODS: We retrospectively evaluated 102 patients who had been diagnosed with non-melanoma skin cancer and treated by MMS from May 2008 to September 2011. RESULTS: The most common cancer was basal cell carcinoma (63.72%), followed by squamous cell carcinoma (31.38%). The local flap was the most common method to repair surgical defects (74.5%), followed by primary closure (17.64%). Cervical lymph node metastasis was confirmed in 1 case (0.98%). Recurrence after MMS was observed in 1 of 102 patients (0.98%). CONCLUSION: MMS is a safe method for the treatment of non-melanoma skin cancer.
